FDA initiatives to support dose optimization in oncology drug development: the less may be the better

Detalles Bibliográficos
Autor principal: Moon, Hanlim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253446/
https://www.ncbi.nlm.nih.gov/pubmed/35800667
http://dx.doi.org/10.12793/tcp.2022.30.e9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253446/
https://www.ncbi.nlm.nih.gov/pubmed/35800667
http://dx.doi.org/10.12793/tcp.2022.30.e9

Ejemplares similares